Patent classifications
A61M5/283
A MEDICAMENT DELIVERY DEVICE
The present invention relates to a medicament delivery device. The medicament delivery device comprises a housing, a needle, a medicament delivery mechanism and an actuator. The needle is moveable from a retracted position, wherein the needle is fully received in the housing, to an extended position, wherein the needle protrudes out of the housing. The medicament delivery mechanism comprises a reservoir and dispensing member each disposed in the housing, first and second biasing members, and first and second locking members. The actuator is moveable relative to the housing from an initial position to an intermediate position such that the actuator exerts a force on the first locking member to urge the first locking member from a locked state to an unlocked state wherein the first biasing member moves the needle from the retracted position to the extended position. The actuator is moveable relative to the housing from the intermediate position to a second position such that the actuator exerts a force on the second locking member to urge the second locking member from a locked state to an unlocked state wherein the second biasing member moves the dispensing member within the housing to dispense medicament from the reservoir when the reservoir contains medicament.
Syringe
A syringe (200, 400) for use in a medication delivery device (100) comprises a vial. The vial (201, 411) comprises a chamber (206). The chamber is configured to receive a piston or plunger (205, 416). The syringe further comprises a needle attachment point (202), for the attachment of a hypodermic needle (204). The chamber is offset from the needle attachment point.
Medication injection system
An automatic injection device is provided, where the device includes a syringe carrier and a retraction assembly. The syringe carrier may include two identical parts that are discrete from one another and interlock with one another. Carrier includes a cushion to support the syringe. Protrusions may be provided on cushion to further support syringe. The retraction assembly includes a shuttle and a follower, the follower having a moveable latch. The follower has a coupled configuration in which the latch is biasedly coupled to the shuttle, and a decoupled configuration in which the latch is in sliding engagement with a curvilinear surface of the shuttle.
Autoinjector
Described is an autoinjector comprising of a case, a motor adapted to rotate a drive gear, and a curvi-linear plunger adapted to mate with the drive gear. The plunger includes a distal end with a resilient flange, which in a non-deflected state, abuts a proximal collar of a syringe, and, in a deflected state, advances through the proximal collar and engages a stopper in the syringe.
DOSE DIVIDER SYRINGE
A syringe includes a barrel having an internal surface defining an internal bore therein; a plunger having a distal end disposed within the internal bore of the barrel, and a proximal end disposed outside the internal bore of the barrel; and a dose divider configured to bear on the barrel in response to translation of the plunger relative to the barrel along the longitudinal direction. The dose divider includes a base including a flange that extends at least partly in a radial direction; and at least one column extending away from the base along the longitudinal direction. The at least one column includes a proximal end and a distal end opposite the proximal end, the proximal end of the at least one column being coupled to the base. The at least one column includes a sacrificial portion coupled to a frangible link.
Motion-activated septum puncturing drug delivery device
A method and apparatus are disclosed for delivery of a drug to a recipient. In some embodiments, the delivery apparatus may unseal a drug containing reservoir. In some embodiments, the delivery rate may be controlled and/or adjustable. Optionally the apparatus may be disposable. Optionally, the apparatus may have a low profile and/or be wearable and/or attachable to the recipient. Optionally, discharge of the drug and/or unsealing of the reservoir may be driven by a plunger moving parallel to the base of the apparatus. Optionally, the apparatus may release a hypodermic needle into the recipient. Optionally, release of the hypodermic needle may be in a direction non-parallel and/or orthogonal to the direction of movement of the plunger. Optionally, prior to release, the hypodermic needle may be preserved in an aseptic state by a needle opening septum sealing a needle opening. Optionally, upon release, the hypodermic needle may pierce the needle opening septum.
Motion activated septum puncturing drug delivery device
A method and apparatus are disclosed for delivery of a drug to a recipient. In some embodiments, the delivery apparatus may unseal a drug containing reservoir. In some embodiments, the delivery rate may be controlled and/or adjustable. Optionally the apparatus may be disposable. Optionally, the apparatus may have a low profile and/or be wearable and/or attachable to the recipient. Optionally, discharge of the drug and/or unsealing of the reservoir may be driven by a plunger moving parallel to the base of the apparatus. Optionally, the apparatus may release a hypodermic needle into the recipient. Optionally, release of the hypodermic needle may be in a direction non-parallel and/or orthogonal to the direction of movement of the plunger. Optionally, prior to release, the hypodermic needle may be preserved in an aseptic state by a needle opening septum sealing a needle opening. Optionally, upon release, the hypodermic needle may pierce the needle opening septum.
DEVICES AND METHODS FOR SYRINGES CONFIGURED TO REDUCE OR ELIMINATE RESIDUAL VOLUME
The present disclosure relates to a syringe including a container, for containing a primary fluid, and at least one secondary fluid chamber configured to contain a secondary fluid. The container comprises a proximal end and a distal end and having a distal end opening at the distal end. The syringe further comprises a stopper, movably arranged within the container; and a plunger engageable with the stopper and configured to apply a force to the stopper to move the stopper within the container towards the distal end of the container, to expel primary fluid from the container through the distal end opening. The plunger is further configured to expel secondary fluid from the at least one secondary fluid chamber towards the distal end opening, to expel at least a portion of a residual volume of primary fluid through the distal end opening. A plunger system and assembly for a syringe and methods of expelling fluid from a syringe are also disclosed.
DISCHARGER WITH IMPROVED PIERCING TIP
A discharger for discharging a predetermined amount of fluid includes a housing defining a longitudinal first axis and having a proximal end and a distal end, a discharge section having a discharge passage for the fluid extending between an inlet opening and an outlet opening of the discharge section, a carriage cooperating with the proximal end region of the housing such that the carriage is moveable relative to the housing along the first axis, the carriage including a receiving space for the fluid, and a piercing tip having a flow channel for establishing a flow connection for the fluid from the receiving space to the inlet opening of the discharge section, the piercing tip defining a centrally extending longitudinal second axis and having a shell surface. The shell surface of the piercing tip has an essentially convexly curved.
DEVICE AND METHOD FOR SAMPLE COLLECTION
The present disclosure provides a device for collecting a bodily fluid sample of a subject for nucleic acid amplification, a method for collecting a bodily fluid sample of a subject for nucleic acid amplification, and a kit for nucleic acid amplification. The device may comprise a device body that is coupled to at least one collection channel including a collection member having an opening at an end thereof to permit flow of the bodily fluid sample from a source thereof to the collection channel. The collection channel may be substantially free of an anticoagulant. The device may further comprise a mechanical member coupled to the device body. The mechanical member may actuate the collection member to (i) extend away from the collection channel for collection of the bodily fluid sample from the source thereof, and (ii) retract into the collection channel upon collection of the sample.